New Glucose-Lowering Agents for Diabetic Kidney Disease.
Sign Up to like & getrecommendations! Published in 2018 at "Advances in chronic kidney disease"
DOI: 10.1053/j.ackd.2018.01.002
Abstract: The prevalence of diabetes mellitus is increasing and is associated with a range of complications including nephropathy. New antidiabetic agents are sought which also have positive effects to diminish diabetic complications. Examples of promising new… read more here.
Keywords: renoprotective effects; disease new; new glucose; kidney disease ... See more keywords
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1101091
Abstract: Adipose tissue malfunction leads to altered adipokine secretion which might consequently contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus, and cardiovascular disorders. Asprosin is a novel diabetogenic adipokine classified as a… read more here.
Keywords: asprosin health; adipose tissue; new glucose; adipokine ... See more keywords